Browse studies
Find your next paid study
4 recruiting studies matching your filters
Observational
Randomized Controlled Trial Comparing endoAVF Versus surgAVF
Patients with end-stage kidney disease (ESKD) who use hemodialysis to filter their blood require vascular access for the dialysis machine; the most common type…
End Stage Renal Disease on Dialysis
Estimated
~$10 – $6,250
University of California, Los AngelesNCT05654103
Phase 2
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety, Tolerability, and Serum Phosphate Lowering Effect of Fixed Dose AP306 in Participants With Hyperphosphatemia Receiving Maintenance Hemodialysis
This study is being conducted to characterize the safety, tolerability, and efficacy of AP306 at fixed doses in adults with hyperphosphatemia receiving mainten…
HyperphosphatemiaChronic Kidney Disease Requiring Chronic DialysisEnd Stage Renal Disease on Dialysis
Estimated
~$10 – $8,750
R1 TherapeuticsNCT06712654
Phase 4
Effect of Empagliflozin on Peritoneal and Kidney Function in End Stage Renal Disease
The main purpose of the study is to determine if empagliflozin can reduce peritoneal glucose absorption in patients with end stage renal diease (ESRD) on perit…
End Stage Renal Disease on Dialysis
Estimated
~$10 – $6,250
Yale UniversityNCT05671991
Observational
Fight Fatigue: A Progressive Muscle Relaxation and Walking Intervention to Reduce Fatigue in Adults With ESKD
Fight Fatigue is evaluating the feasibility and acceptability of a combined progressive muscle relaxation and walking intervention to reduce fatigue for adults…
End Stage Renal Disease on Dialysis
Estimated
~$10 – $6,250
University of Illinois at ChicagoNCT07014111